Concepedia

Arthur J. Van De Vyver

AJ

Statistics

Publications

3

Citations

68

H-Index

3

Active since

2020

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

Arthur J. Van De Vyver is an author at Roche (Switzerland) specializing in medicine, drug discovery, and pharmacokinetics.

ORCID

Top concepts

Publications per year

2020–2022

3

Publications

3

Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab

Nicolas Frances, Marina Bacac, Katharine Bray‐French et al. · Journal of Pharmaceutical Sciences · 2021 · 29 citations

, , +5

Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining <i>In Vitro</i> Experiments with Systems Modeling

Arthur J. Van De Vyver, Tina Weinzierl, Miro J. Eigenmann et al. · Molecular Cancer Therapeutics · 2020 · 25 citations · Full text

Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration

Arthur J. Van De Vyver, Antje‐Christine Walz, Mariette Heins et al. · Frontiers in Pharmacology · 2022 · 14 citations · Full text

1–3 of 3